RxDoctor Payments Data

Julie Sieben

Gerontology · Harwich Port, MANPI 1396077764

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 54 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by AbbVie at 31.7% of the total. Reporting peaked in 2022 at $548 and has fallen 61.7% since, to $210 in 2025.

$1,425in general payments, 2019–2025

Across 54 payments — averaging $26.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$451
  • Lilly USA, LLC$178
  • Lundbeck LLC$172
  • Boston Scientific$133
  • Sanofi$82
  • Biohaven Pharmaceuticals, Inc.$70
  • plus $339 from 10 others

What the payments were for

  • Food & beverage$1,425100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,425 in reported general payments places this provider in the 85th percentile of 168 gerontology providers in Massachusetts.

See all gerontology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$55,665
Medicare patients
275
Services billed
518

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Rosuvastatin Calcium27$715
Metoprolol Succinate31$679
Atorvastatin Calcium46$631
Omeprazole24$496
Gabapentin44$454
ClopidogrelClopidogrel Bisulfate18$404
Levothyroxine Sodium41$378
Lisinopril29$337
Losartan Potassium29$289
Pravastatin Sodium12$192
Amlodipine Besylate28$191
Methylprednisolone14$139
Pregabalin17$116
Glipizide11$95
Prednisone16$65

Paid to pharmacies, not to this prescriber.

Other gerontology in Harwich Port

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →